March 08, 2022
As per the report titled ‘Global Clinical Decision Support Systems Market Size study, By Product (Standalone CDSS, Integrated EHR With CDSS), By Application (Drug-drug Interactions, Drug Allergy Alerts, Others), By Delivery Mode (Web-based Systems, Cloud-based Systems, On-premise Systems), By Component (Hardware, Software, Services) and Regional Forecasts 2021-2027’, available with MarketStudyReport, global clinical decision support systems market value is anticipated to increase from USD 4.15 billion in 2020 to USD 7.9 billion by the end of the assessment period, with a CAGR of 9.7% throughout.
Rising government expenditure towards adoption of health IT solutions like remote monitoring of patient care and diagnostic technologies for liver, lung, and bowel along with technological innovations are fueling global clinical decision support systems market growth.
Request sample copy of this report: https://www.marketstudyreport.com/request-a-sample/4566285/
For the uninitiated, clinical decision support systems are digital programs utilized to assess data and provide prompts & reminders for healthcare monitoring. It assists in effective management of data in the healthcare sector. These systems are available as standalone CDSS or CDSS with integrated EHR, and can be deployed as web-based, cloud-based, or on-premise. They have various applications, including drug-drug interactions, drug allergy alerts, and others.
Despite the positive industry, lack of trained professionals is likely to stifle the industry growth over 2021-2027.
From a geographical perspective, North America (U.S., Canada), Europe (France, Spain, Germany, U.K., Italy), Asia Pacific (India, China, Japan, Australia, South Korea), and Latin America (Brazil, Mexico) are the major geographies highlighted in the document.
North America currently holds a major portion of global clinical decision support systems industry share, creditable to increasing technological advancements in the healthcare sector. Meanwhile, the industry in Asia Pacific is touted to record a remarkable growth rate through 2027 on account of factors such as increasing R&D activities by governments and rising penetration of digital technologies in the medical field.
Speaking of the competitive landscape, Wolters Kluwer N.V., Agfa-Gevaert Group, IBM Corporation, Koninklijke Philips N.V., NextGen Healthcare Inc., Athenahealth, Inc., Allscripts Healthcare, LLC, Siemens Healthineers GmbH, Cerner Corporation, and McKesson Corporation are the major contenders in this domain.